In cooperation with colleagues in Munich and Göttingen, researchers at the German Center for Neurodegenerative Diseases (DZNE) in Bonn have analyzed a novel substance that could serve as a prototype for the development of drugs to treat Alzheimers and other brain diseases. Known as anle138b, this substance ameliorated disease symptoms in mice and improved their cognition. The scientists report on these findings in the journal Acta Neuropathologica.
“We have found that this substance prevents the aggregation of tau proteins. This aggregation is typical of Alzheimer’s and other brain diseases classified as tauopathies,” explains DZNE researcher Dr. Martin Fuhrmann, who worked on this study with colleagues at the Ludwig-Maximilians-University Munich (LMU) and the Max Planck Institute for Biophysical Chemistry in Göttingen. “Treatment with anle138b could be one way of intervening in the progress of the disease.”
Effect on pathologically altered protein
Under normal conditions, the tau proteins stabilize the microtubules that are part of the cytoskeleton of neurons in the brain. The cytoskeleton gives the cell mechanical stability and serves as a transport network for substances essential to the cell’s metabolism.
However, in cases of Alzheimer’s disease and other tauopathies, the tau proteins have undergone an alteration: they become detached from microtubules and aggregate into filamentous tau-tangles. As a result, the microtubules’ function and the cell’s metabolism are impaired, which eventually leads to neuronal death.
Amelioration of disease symptoms
“The experiments were inspired by our earlier studies that showed high efficacy against the formation of pathological protein aggregation,” says Prof. Armin Giese from the Center for Neuropathology and Prion Research at the LMU Munich. “These led us to suspect that anle138b could prevent the aggregation of tau proteins.”
The mice treated by the scientists had a genetic defect that caused them to display various characteristics typical of tauopathies, the same as those that manifest in humans. Besides aggregation of tau proteins, these include cognitive disorders and a shorter life expectancy. It turned out that the substance, which was administered in the mice’s food, not only works at molecular level but also influences disease symptoms. “The mice’s working memory skills improved and they lived longer,” says Fuhrmann. The scientists also found that the treated mice had less neuron loss than those that had not been treated.
Disease development apparently slowed
“In contrast to other substances Anle138b is orally available because of its chemical and metabolic characteristics. Therefore, it stays for hours within the body and targets specifically protein aggregation”, says Prof. Christian Griesinger from the Max Planck Institute for Biophysical Chemistry, whose team synthesized the substance.
“Anle138b cannot stop the disease from progressing in the animal model, but it seems to slow it down,” says DZNE scientist Fuhrmann. “Anle138b is therefore a possible starting point for the development of drugs that prevent the aggregation of tau proteins.” However, the results from mice are not directly transferable to human. “The efficacy and tolerance for humans have to be tested in demanding clinical trials. Even with an optimistic perspective it will take years until a treatment for patients might be available.” Currently, a joint venture of LMU and MPG develops the drug Anle138b further.
Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
Jens Wagner, Sybille Krauss, Song Shi, Sergey Ryazanov, Julia Steffen, Carolin Miklitz, Andrei Leonov, Alexander Kleinknecht, Bettina Göricke, Jochen H. Weishaupt, Daniel Weckbecker, Anne M. Reiner, Wolfgang Zinth, Johannes Levin, Dan Ehninger, Stefan Remy, Hans A. Kretzschmar, Christian Griesinger, Armin Giese, Martin Fuhrmann.
Acta Neuropathologica, DOI:10.1007/s00401-015-1483-3.
Dr. Marcus Neitzert | idw - Informationsdienst Wissenschaft
How brains surrender to sleep
23.06.2017 | IMP - Forschungsinstitut für Molekulare Pathologie GmbH
A new technique isolates neuronal activity during memory consolidation
22.06.2017 | Spanish National Research Council (CSIC)
An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.
Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...
Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.
Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...
Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.
As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...
Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.
With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...
Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine
Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...
19.06.2017 | Event News
13.06.2017 | Event News
13.06.2017 | Event News
23.06.2017 | Physics and Astronomy
23.06.2017 | Life Sciences
23.06.2017 | Information Technology